Literature DB >> 915002

Lead poisoning. Further observations on erythrocyte pyrimidine-nucleotidase deficiency and intracellular accumulation of pyrimidine nucleotides.

D E Paglia, W N Valentine, K Fink.   

Abstract

Pyrimidine nucleotides, detectable in normal erythrocytes only in trace quantities if at all, were found to comprise 7-80% of the intracellular nucleotide pools in nine subjects with severe lead over-burden. Blood lead concentrations ranged from approximately equal to 200- to 400-microgram/dl packed cells, and the greatest accumulations of pyrimidine-containing nucleotides occurred in the two subjects with the highest blood lead levels. Most of the patients had mild or moderate anemia and moderate basophilic stippling evident in Wright's-stained peripheral smears. Pyrimidine nucleotidase activities were inhibited to 13-28% of the mean activity in normal control erythrocytes and even more so (5-15%) when compared to specimens with increased reticulocytes and young cells. Reticulocytosis was absent in two subjects and modest to moderate in the remainder, but erythrocyte assays revealed the substantial elevations in populations of young mean cell age. Inappropriately low reticulocyttial elevations in glucose-6-phosphate dehydrogenase expected in populations of young mean cell age. Inappropriately low reticulocyte responses may reflect hematopoietic suppressive effects of lead at a variety of metabolic loci.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 915002      PMCID: PMC372493          DOI: 10.1172/JCI108896

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  16 in total

1.  Human red cell glycolytic intermediates.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

2.  Changes in the nucleotides of stored or incubated human blood.

Authors:  C BISHOP
Journal:  Transfusion       Date:  1961 Nov-Dec       Impact factor: 3.157

3.  Simultaneous multiple-column chromatography: its application to the separation of the adenine nucleotides of human erythrocytes.

Authors:  C DE LUCA; J H STEVENSON; E KAPLAN
Journal:  Anal Biochem       Date:  1962-07       Impact factor: 3.365

4.  The nucleotides in normal human blood.

Authors:  C BISHOP; D M RANKINE; J H TALBOTT
Journal:  J Biol Chem       Date:  1959-05       Impact factor: 5.157

5.  The metabolism of nucleotides and other phosphate esters in erythrocytes during in vitro incubation at 37 degrees.

Authors:  G C MILLS; L B SUMMERS
Journal:  Arch Biochem Biophys       Date:  1959-09       Impact factor: 4.013

6.  A simple rapid radiometric assay for pyrimidine-5'-nucleotidase.

Authors:  J Torrance; C West; E Beutler
Journal:  J Lab Clin Med       Date:  1977-09

7.  Hereditary hemolytic anemia with human erythrocyte pyrimidine 5'-nucleotidase deficiency.

Authors:  W N Valentine; K Fink; D E Paglia; S R Harris; W S Adams
Journal:  J Clin Invest       Date:  1974-10       Impact factor: 14.808

8.  Studies on erythrocyte glycolysis. I. Determination of the glycolytic intermediates in human erythrocytes.

Authors:  S Minakami; C Suzuki; T Saito; H Yoshikawa
Journal:  J Biochem       Date:  1965-12       Impact factor: 3.387

9.  Lead poisoning: association with hemolytic anemia, basophilic stippling, erythrocyte pyrimidine 5'-nucleotidase deficiency, and intraerythrocytic accumulation of pyrimidines.

Authors:  W N Valentine; D E Paglia; K Fink; G Madokoro
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

10.  Hereditary hemolytic anemia with erythrocyte pyrimidine 5'-nucleotidase deficiency in Spain. Clinical, biological and familial studies.

Authors:  J L Vives-Corrons; E Montserrat-Costa; C Rozman
Journal:  Hum Genet       Date:  1976-12-15       Impact factor: 4.132

View more
  10 in total

1.  Determination of pyrimidine 5'-nucleotidase (P5N) activity in whole blood as an index of lead exposure.

Authors:  T Sakai; T Araki; K Ushio
Journal:  Br J Ind Med       Date:  1988-06

2.  Identification of thymidine nucleotidase and deoxyribonucleotidase activities among normal isozymes of 5'-nucleotidase in human erythrocytes.

Authors:  D E Paglia; W N Valentine; R A Brockway
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

3.  A role of red cell pyrimidine 5'-nucleotidase in experimental lead poisoning.

Authors:  H Fujii
Journal:  Arch Toxicol       Date:  1979-10       Impact factor: 5.153

4.  A simplified method for determining erythrocyte pyrimidine 5'-nucleotidase (P5N) activity by HPLC and its value in monitoring lead exposure.

Authors:  T Sakai; K Ushio
Journal:  Br J Ind Med       Date:  1986-12

5.  Erythrocyte pyrimidine 5'-nucleotidase activity in workers exposed to lead, mercury or cadmium.

Authors:  B Mohammed-Brahim; J P Buchet; R Lauwerys
Journal:  Int Arch Occup Environ Health       Date:  1985       Impact factor: 3.015

6.  Erythrocyte arginase, pyrimidine 5'-nucleotidase (P5N), and deoxypyrimidine 5'-nucleotidase (dP5N) as indices of lead exposure.

Authors:  L R Cook; C R Angle; S J Stohs
Journal:  Br J Ind Med       Date:  1986-06

7.  Erythrocyte nucleotides in lead workers.

Authors:  M Ichiba; K Tomokuni; K Mori
Journal:  Int Arch Occup Environ Health       Date:  1992       Impact factor: 3.015

8.  Comparative study of effects of lead on the activity of erythrocyte pyrimidine 5'-nucleotidase and delta-aminolevulinate dehydratase in vivo and in vitro.

Authors:  K Tomokuni; M Ogata
Journal:  Arch Toxicol       Date:  1980-09       Impact factor: 5.153

9.  Evaluation of lead exposure in workers at a lead-acid battery factory in Korea: with focus on activity of erythrocyte pyrimidine 5'-nucleotidase (P5N).

Authors:  Y Kim; K Harada; S Ohmori; B K Lee; H Miura; A Ueda
Journal:  Occup Environ Med       Date:  1995-07       Impact factor: 4.402

Review 10.  Evaluation and management of lead exposure.

Authors:  Hwan-Cheol Kim; Tae-Won Jang; Hong-Jae Chae; Won-Jun Choi; Mi-Na Ha; Byeong-Jin Ye; Byoung-Gwon Kim; Man-Joong Jeon; Se-Yeong Kim; Young-Seoub Hong
Journal:  Ann Occup Environ Med       Date:  2015-12-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.